SEC 13F Intelligence

Bnc Wealth Management, LLC / REGN

Bnc Wealth Management, LLC’s Regeneron Pharmaceuticals Position

Does Bnc Wealth Management, LLC own Regeneron Pharmaceuticals (REGN)? Not currently — the last reported position was 2.6K shares worth $2M in Q1 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q1 2023
Shares
2.6K
% of Portfolio
+1.17%
Quarters Held
3
position exited

Position History REGN

Reported value by quarter
Q3 ’20: $578,000Q3 ’20Q3 ’22: $1MQ3 ’22Q1 ’23: $2MQ1 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20232.6K$2M+1.17%
Q3 20221.7K$1M+0.72%
Q3 20201.0K$578,000+0.41%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bnc Wealth Management, LLC’s full portfolio or all institutional holders of REGN.